Antiviral therapy of chronic hepatitis B. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Antiviral Research Année : 2006

Antiviral therapy of chronic hepatitis B.

Résumé

Treatment of chronic hepatitis B remains a clinical challenge. Long-term viral suppression is a major goal of antiviral therapy to improve the clinical outcome of the patients. Antiviral treatment of chronic hepatitis B relies currently on immune modulators such as interferon alpha and its pegylated form, and viral polymerase inhibitors. Because of the slow kinetics of viral clearance and the spontaneous viral genome variability, viral mutants resistant to nucleoside analogs may be selected. However, the development of new antiviral agents is rapidly improving the offing of therapy of chronic hepatitis B. These new therapeutic advances are reviewed in this manuscript.
Fichier principal
Vignette du fichier
AVRzoulimrevised2006.pdf (343.48 Ko) Télécharger le fichier
Loading...

Dates et versions

inserm-00134589 , version 1 (02-03-2007)

Identifiants

Citer

Fabien Zoulim. Antiviral therapy of chronic hepatitis B.. Antiviral Research, 2006, 71 (2-3), pp.206-15. ⟨10.1016/j.antiviral.2006.04.003⟩. ⟨inserm-00134589⟩
30 Consultations
374 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More